Trials / Conditions / Platinum-Sensitive Fallopian Tube Carcinoma
Platinum-Sensitive Fallopian Tube Carcinoma
3 registered clinical trials studyying Platinum-Sensitive Fallopian Tube Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors NCT05002868 | Rhizen Pharmaceuticals SA | Phase 1 |
| Active Not Recruiting | Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurr NCT04034927 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen i NCT03691376 | Roswell Park Cancer Institute | Phase 1 |